Morbidity and mortality associated with respiratory virus infections in allogeneic hematopoietic cell transplant: Too little defense or harmful immunity? Journal Article


Authors: Versluys, A. B.; Boelens, J. J.
Article Title: Morbidity and mortality associated with respiratory virus infections in allogeneic hematopoietic cell transplant: Too little defense or harmful immunity?
Abstract: The impact on morbidity and mortality of Community Acquired Respiratory Virus (CARV) infections in patients undergoing Allogeneic Hematopoietic Cell Transplant (HCT) is widely studied. Here we give an overview of the current literature on the incidence and chance of progression to severe disease in this highly immune compromised population. We discuss the issue whether it is predominantly direct viral damage that causes clinical deterioration, or that it is in fact the allogeneic immuneresponse to the virus that is most important. This is an important question as it will guide therapeutic decision making. It asks for further collaborative studies focusing on sensitive surveillance with PCR techniques and relating clinical data with parameters of immune reconstitution. © 2007 - 2018 Frontiers Media S.A.
Keywords: lung disease; outcome; respiratory virus infection; alloimmunity and transplantation; allogeneic transplant of hematopoietic stem cells
Journal Title: Frontiers in Microbiology
Volume: 9
ISSN: 1664-302X
Publisher: Frontiers Media S.A.  
Date Published: 2018-11-21
Start Page: 2795
Language: English
DOI: 10.3389/fmicb.2018.02795
PROVIDER: scopus
PMCID: PMC6258814
PUBMED: 30519222
DOI/URL:
Notes: Front. Microbiol. -- Export Date: 2 January 2019 -- Review -- Source: Scopus C7 - 02795
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jaap Jan Boelens
    211 Boelens